About GenScript
GenScript Biotech Corporation (Stock Code: 1548.HK) is a global biotechnology group. Founded in 2002, GenScript has an established global presence across North America, Europe, the Greater China, and Asia Pacific. GenScript's businesses encompass four major categories based on its leading gene synthesis technology, including operation as a Life Science CRO, enzyme and synthetic biology products, biologics development and manufacturing, and cell therapy.
GenScript is committed to striving towards its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology
About ProBio
ProBio proactively provides end-to-end CDMO service from drug discovery to commercialization with proactive strategies, professional solutions and efficient processes in cell and gene therapy (CGT), vaccine, biologics discovery and antibody protein drug to accelerate drug development for customers. ProBio’s total cell and gene therapy solution covers CMC of plasmid and virus for IND filing as well as clinical manufacturing and commercial manufacturing. In terms of plasmid service, ProBio supports the most clinical approvals for CGT drugs including mRNA vaccines, CAR-T in China. It is also the first GMP manufacturing platform to provide in vitro transcription (IVT) template linearized plasmids for mRNA vaccines and has supported several mRNA vaccine global enterprises to obtain clinical approvals. In terms of viral vector service, \ProBio has a stable and high-yield viral vector platform.
Job Scope:
The position reports to the Sr. QC Manager, is ideally suited for a professional with technical knowledge, and exposure to developing and carrying out processes, that are suitable for use in GMP manufacturing of a wide range of clinical trial materials, and participating in the technology transfer. There is a great opportunity to learn this function within a CDMO business, to support a broad portfolio and advance the manufacturing capabilities to deliver products to the client projects that transform the lives of patients.
- Perform a wide range of analytical tests, including but not, UV-Spectrophotometry, qPCR, ELISA, HPLC, Endotoxin, MicroBCA, Electrophoresis, and DNA Sequencing/Analysis.
- Support QC-Analytics initiatives including equipment qualification, method development, method validation, and tech-transfer. Execute protocols related to QC-Analytic initiatives.
- Ensure compliance with cGMP and regulatory requirements.
- Develop and lead optimization initiatives to improve QC department.
- Responsible for following cGMP in carrying out functions related to QC testing.
- Perform other duties, as assigned based on business needs.
Qualifications:
- Bachelor’s degree with 1-2 years of relevant work experience. Degree in Molecular Biology, Biochemistry, Microbiology or related scientific field. Experience in gene and cell therapy recombinant plasmid DNA products a plus.
- Experience working with QC intermediate and release testing, raw material testing, or validation testing.
- Experience working with Electrophoresis, UV-Spectrophotometry, HPLC, qPCR, ELISA or DNA Sequencing/Analysis.
- Experience testing plasmid DNA. Experience testing viral vectors is a plus.
- Familiar with principles of Good Documentation Practices, Data Integrity, ALCOA+
- Experience following Standard Operating Procedures or protocols
- Ability to problem solve, and work independently and as part of a team. Emphasis on the ability to work in a team atmosphere.
- Experience with Microsoft Office tools. Experience with statistics, coding, programming, troubleshooting, and/or data management software is a plus.
- Strong interpersonal, verbal, and written communication skills.
- Exposure to documentation life cycle, by way of authoring, reviewing and/or approving GMP documents, such as procedures, test methods, protocols, reports, etc.
#PB
GenScript USA Inc/ProBio Inc. is a proud equal opportunity/affirmative action employer committed to attracting, retaining, and maximizing the performance of a diverse and inclusive workforce. It is the Company's policy to ensure equal employment opportunity without discrimination or harassment based on race, color, religion, sex (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity or expression, age, disability, national origin, marital or domestic/civil partnership status, genetic information, citizenship status, uniformed service member or veteran status, or any other characteristic protected by law.
GenScript USA Inc./ProBio Inc. maintains a drug-free workplace.
Top Skills
What We Do
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions worldwide have used GenScript’s premier, convenient, and reliable products and services. GenScript currently has over 5,000 employees globally, 33% holding master’s and/or Ph.D. degrees. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis, and bioinformatics, including more than 100 patents and over 270 patent applications. As of June 2022, GenScript's products and services have been cited by 74,700 scientific papers worldwide. GenScript is committed to striving toward its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.
